Search
Ginkgo Bioworks Holdings Inc
DNAAdd to Watchlist
12.330USD
+1.040+9.21%
Market hours 11/09, 10:25（ET）
793.31MMarket Cap
LossP/E TTM
Today
+9.21%
5 Days
+9.99%
1 Month
+8.73%
6 Months
+38.07%
Year to Date
+48.38%
1 Year
+37.77%
Key Figures
11.270Open
12.410High
153.21KVolume
LossP/E TTM
0.00P/E Dynamic
--Dividend TTM
0.24%Turnover Ratio
11.290Prev. Close
9.985Low
1.82MTurnover
LossP/E Static
1.89P/B
0.00%Div Yield TTM
-26.26%ROA
18.22052wk High
0.38Volume Ratio
-547.03MNet Profit
64.34MShares
-5.3493EPS TTM
1.80Beta
-56.03%ROE
5.37052wk Low
21.48%Amplitude
91.47%Gross Margin
793.31MMarket Cap
-2.02Reward/Risk
6.48%Risk Rate
Ginkgo Bioworks Holdings Inc's Score
0.16vs previous score
Forecast3.33
Financial Health7.12
Technical5.46
Valuation Dimensions6.60
Institutional Confidence5.00
Risk Assessment2.45
Media Coverage
Coverage Level
Very Low
Very High
Negative-
Analyst Rating
Ginkgo Bioworks Holdings Inc Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy
Ginkgo Bioworks Holdings Inc Latest Earnings Call Transcripts
Ginkgo Bioworks (DNA) Q3 2026 Earnings Call: Autonomous Lab Wins and Cash Burn Guidance
Ginkgo Bioworks Q3 2026 revenue fell 6% to $28 million as losses narrowed. DNA reaffirmed $125 million-$150 million cash burn guidance and added autonomous lab wins.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
--/-0.87
Revenue / Forecast
--/21.57M
Ginkgo Bioworks Holdings Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolDNA
Number of employees834
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Cascade Investment, L.L.C. | 6.79% |
| Viking Global Investors LP | 6.70% |
| BlackRock Institutional Trust Company, N.A. | 6.05% |
| Baillie Gifford & Co. | 4.48% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 28.38% |
| Investment Advisor/Hedge Fund | 20.88% |
| Family Office | 6.79% |
| Hedge Fund | 6.54% |
Related Instruments
+3.15%
+0.30%
-0.04%
+0.29%
-0.16%
+1.22%
-0.30%
+1.03%
+1.33%
-0.80%
-0.58%
-0.23%
+0.01%
+1.67%
+7.36%
+1.11%
+0.71%
-0.31%
+1.10%
+2.87%Popular Instruments
52118.700
+828.100 (+1.61%)
27702.000
+737.500 (+2.73%)
7511.900
+131.900 (+1.79%)
12797.000
-1.000 (-0.01%)
60480.000
+2338.000 (+4.02%)
6289.200
+148.600 (+2.42%)
86.982
-2.875 (-3.20%)
350.270
+7.900 (+2.31%)
178.120
-8.520 (-4.57%)
4116.850
+51.180 (+1.26%)
FAQs
What is the current price of Ginkgo Bioworks Holdings Inc (DNA)?
The current price of Ginkgo Bioworks Holdings Inc (DNA) is 11.29.
What is the symbol of Ginkgo Bioworks Holdings Inc?
The ticker symbol of Ginkgo Bioworks Holdings Inc is DNA.
What is the 52-week high of Ginkgo Bioworks Holdings Inc?
The 52-week high of Ginkgo Bioworks Holdings Inc is 18.22.
What is the 52-week low of Ginkgo Bioworks Holdings Inc?
The 52-week low of Ginkgo Bioworks Holdings Inc is 5.37.
What is the market capitalization of Ginkgo Bioworks Holdings Inc?
The market capitalization of Ginkgo Bioworks Holdings Inc is 726.40M.
Is Ginkgo Bioworks Holdings Inc (DNA) currently rated as Buy, Hold, or Sell?
According to analysts, Ginkgo Bioworks Holdings Inc (DNA) has an overall rating of Sell, with a price target of 8.00.
What is the Earnings Per Share (EPS TTM) of Ginkgo Bioworks Holdings Inc (DNA)?
The Earnings Per Share (EPS TTM) of Ginkgo Bioworks Holdings Inc (DNA) is -5.35.